Abiopharma

Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ™ for Leptomeningeal Metastases

Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11

Trevi Therapeutics Provides Strategic Updates Ahead of Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference

Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology

Indivior Notification

Canopy Growth Communication - Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy

Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing

Anika Therapeutics Announces Leadership Transition